Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail DAIDSRSCwebsitesupport@tech-res.com for assistance.

Drugs

Drug Name Sort descending Drug Company PI Date Risk List Available?
Rifampicin/Isoniazid (Isonarif) VersaPharm Incorporated March 2012
Rifampicin/Isoniazid/Pyrazinamide/Ethambutol Hydrochloride Macleods Pharmaceuticals Ltd October 2018
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Rifapentine - New Macleods Pharmaceuticals Ltd June 2026
Rifapentine - New Macleods Pharmaceuticals Ltd July 2025
Rifapentine (Priftin) - New Sanofi-Aventis January 2026 YES
Rilpivirine (Edurant) Janssen November 2024 YES
Tenofovir Disoproxil Fumarate (Viread) Gilead Sciences April 2019 YES
Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir Mylan Laboratories Limited July 2017
Vorinostat (Zolinza) Merck July 2022
Zidovudine (Retrovir) Capsules, Syrup and IV Injection GlaxoSmithKline November 2024 YES